Loss of Eyebrows and Eyelashes During Concomitant Treatment with Sitagliptin and Metformin.

Abstract

The fixed dose combination of sitagliptin 50 mg and metformin 850 mg (Janumet ®), is indicated for the treatment of type 2 diabetes mellitus in addition to diet and exercise to improve glycemic control in patients treated with metformin alone. METHODS We report a 69-year-old man with type 2 diabetes that developed sudden loss of eyebrows and eyelashes… (More)
DOI: 10.2174/1574886311666161014125536

Topics

Cite this paper

@article{Succurro2017LossOE, title={Loss of Eyebrows and Eyelashes During Concomitant Treatment with Sitagliptin and Metformin.}, author={Elena Succurro and Caterina Palleria and Mariafrancesca Ruffo and Raffaele Serra and Franco Arturi and Luca Gallelli}, journal={Current drug safety}, year={2017}, volume={12 1}, pages={10-12} }